Antigua and Barbuda vs Tajikistan: HIV-positive TB patients on ART (antiretroviral therapy)
Antigua and Barbuda
100.0%
in 2022
Tajikistan
100.0%
in 2024
Antigua and Barbuda rank
1st
Tajikistan rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Antigua and Barbuda
- Tajikistan
How they compare
Antigua and Barbuda currently reports 100.0% against 100.0% in Tajikistan, a difference of 0.0%.
Across all 6 years both countries report, Antigua and Barbuda has been ahead every year.
Antigua and Barbuda ranks 1st and Tajikistan ranks 1st of 144 countries.
Antigua and Barbuda has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Antigua and Barbuda | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 100.0% | 74.0% | 26.0% | Antigua and Barbuda |
| 2020s | 100.0% | 91.0% | 9.0% | Antigua and Barbuda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Antigua and Barbuda or Tajikistan?
- Antigua and Barbuda, at 100.0% against 100.0% in Tajikistan as of 2022.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Antigua and Barbuda and Tajikistan?
- 0.0%, with Antigua and Barbuda ahead.
- How many years of comparable data are there for Antigua and Barbuda and Tajikistan?
- 6 years are reported by both, from 2010 to 2022.
- How do Antigua and Barbuda and Tajikistan rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Antigua and Barbuda ranks 1st and Tajikistan ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.